Effectiveness of Ribociclib Following Radiation in Children with Diffuse Pontine Gliomas

Full IRB Study Title:
CLEE011XUS17T: A Phase I/II Study of Ribociclib, a CDK4/6 Inhibitor, Following Radiation Therapy in Children with Newly-diagnosed Non-biopsied Diffuse Pontine Gliomas (DIPG) and RB+ Biopsied DIPG and High-grade Gliomas (HGG)

IRB Study ID: 969528-2

For complete information, please view the study on clinicaltrials.gov

This study is being done in collaboration with Cincinnati Children's Hospital.

Akron Children‘s Anywhere Mobile App

Managing your child‘s health, made easier

Akron Children‘s Anywhere Mobile App

Managing your child‘s health, made easier

Akron Children‘s Anywhere is designed to be your “go-to app” for managing your child‘s health. It provides tools for finding a primary care doctor or specialist, finding locations and directions, and making everyday health decisions as well as giving you quick, secure access to MyChart and other tools. And when your child needs care, the renowned experts at Akron Children‘s are just one tap away.

Apple App Store Anywhere Mobile App Download Button

Google Play Anywhere Mobile App Download Button

By using this site, you consent to our use of cookies. To learn more, read our privacy policy.